標題: Titlebook: Bioprocess and Analytics Development for Virus-based Advanced Therapeutics and Medicinal Products (A; Saurabh Gautam,Abhilash I. Chiramel, [打印本頁] 作者: 新石器時代 時間: 2025-3-21 16:54
書目名稱Bioprocess and Analytics Development for Virus-based Advanced Therapeutics and Medicinal Products (A影響因子(影響力)
書目名稱Bioprocess and Analytics Development for Virus-based Advanced Therapeutics and Medicinal Products (A影響因子(影響力)學科排名
書目名稱Bioprocess and Analytics Development for Virus-based Advanced Therapeutics and Medicinal Products (A網(wǎng)絡公開度
書目名稱Bioprocess and Analytics Development for Virus-based Advanced Therapeutics and Medicinal Products (A網(wǎng)絡公開度學科排名
書目名稱Bioprocess and Analytics Development for Virus-based Advanced Therapeutics and Medicinal Products (A被引頻次
書目名稱Bioprocess and Analytics Development for Virus-based Advanced Therapeutics and Medicinal Products (A被引頻次學科排名
書目名稱Bioprocess and Analytics Development for Virus-based Advanced Therapeutics and Medicinal Products (A年度引用
書目名稱Bioprocess and Analytics Development for Virus-based Advanced Therapeutics and Medicinal Products (A年度引用學科排名
書目名稱Bioprocess and Analytics Development for Virus-based Advanced Therapeutics and Medicinal Products (A讀者反饋
書目名稱Bioprocess and Analytics Development for Virus-based Advanced Therapeutics and Medicinal Products (A讀者反饋學科排名
作者: auxiliary 時間: 2025-3-21 20:51
Law and the Family in Ireland, 1800–1950t supply. Since infectivity assays are rather complex and there is a variety of different assay formats, this chapter provides a methodological background, as well as tips and tricks regarding the development and performance of infectivity assays.作者: 容易生皺紋 時間: 2025-3-22 01:47
Book 2023so highlights new innovativetools and interdisciplinary techniques for bioprocess development and analytics of viruses and viral vectors. As such, it provides a timely and highly relevant resource, since current advances in pharmaceutical research have seen the rise of vaccines and advanced therapeu作者: 迅速成長 時間: 2025-3-22 06:29 作者: DOLT 時間: 2025-3-22 11:52 作者: 媽媽不開心 時間: 2025-3-22 15:29 作者: 擺動 時間: 2025-3-22 17:23 作者: 中和 時間: 2025-3-22 21:12
Viral Vector Upstream Processing and Clarification,Examples of both adherent and suspension upstream processes are given, down to the different harvesting strategies available. Finally, differences in clarification step processing depending on the upstream process are described.作者: 加入 時間: 2025-3-23 01:48 作者: iodides 時間: 2025-3-23 08:49 作者: Ardent 時間: 2025-3-23 12:09 作者: 和平主義者 時間: 2025-3-23 14:35 作者: Fecundity 時間: 2025-3-23 18:22
Quantification of Virus Infectivity: The Key Assay for the Development of Viral Therapeutics,t supply. Since infectivity assays are rather complex and there is a variety of different assay formats, this chapter provides a methodological background, as well as tips and tricks regarding the development and performance of infectivity assays.作者: 刪除 時間: 2025-3-23 23:21 作者: 運動性 時間: 2025-3-24 03:41 作者: needle 時間: 2025-3-24 10:25
https://doi.org/10.1007/978-1-349-14295-8d for each method, followed by practical aspects relevant to the measurement of rAAV samples and recommendations based on the authors’ experience. Importantly, the list of methods presented here is not exhaustive, but rather a selection of methods that are currently established and commonly used for the quality assessment of rAAV samples.作者: 妨礙 時間: 2025-3-24 11:11
,Murder in the Irish Family, 1930–1945,s are largely removed. Existing methods used for biophysical characterization of virus preparations to begin defining their composition are reviewed in this chapter. With knowledge of the target profile, a strategy to exploit such physical characteristics (e.g., surface charge, size, stability) for process optimization can be devised.作者: depreciate 時間: 2025-3-24 18:07 作者: vanquish 時間: 2025-3-24 21:28 作者: 帶來墨水 時間: 2025-3-25 00:11 作者: 狂熱文化 時間: 2025-3-25 06:11
Book 2023culties within in all the necessary steps of viral vector development -from scalability to purification methods and quality control...The book is intended for researchers working in academia or industry, as well as graduate students pursuing a career in virology..作者: 全部逛商店 時間: 2025-3-25 11:10 作者: 四指套 時間: 2025-3-25 12:13 作者: 完成 時間: 2025-3-25 17:29
Upstream Processing of Viral Therapeutics: From Host Cell Expansion to Virus Production,y. But this new category of potent therapeutics has brought a lot of challenges to the manufacturing process. Compared to viral vaccines, the required dose of virus particles for cancer or gene therapy is significantly high. This emphasizes the need for an efficient production process. Nevertheless,作者: CAJ 時間: 2025-3-25 20:38 作者: debble 時間: 2025-3-26 04:13
Overview of Current Downstream Processing for Modern Viral Vectors,iral vector production strategies must rapidly evolve to keep up with this increased demand for diversity and yield. Downstream purification processes are often a bottleneck during viral vector manufacturing. Challenges include a lack of standardization, low recovery, poor scalability, and maintaini作者: 哥哥噴涌而出 時間: 2025-3-26 08:23 作者: myocardium 時間: 2025-3-26 11:50
Chromatographic Purification of Viruses: State of the Art and Current Trends,cient application in the public healthcare system, they must be proven to be effective and meet the regulatory requirements. The latter also concerns the product purity, relating, among others, to proteins and DNA of the host cells, which are used for virus amplification. As these contaminants may c作者: Chronological 時間: 2025-3-26 15:41
Purifying Viral Vectors: A Review of Chromatography Solutions,for efficient methods for their production and purification. In this chapter, we provide an overview of chromatography methods and their applicability to viral vector processing. Focusing on AAVs and LVs, we review the literature and discuss the values and limitations of resins, membranes, and monol作者: 引起 時間: 2025-3-26 19:01
Particle Analytics: Comparative Approaches for Analysis of Viral Vectors,eans of providing transformative therapeutic results. However, to be able to fulfill this potential the virus particles must be produced reliably in a high-quality fashion. The properties to which each viral preparation is measured up to are related to the two components that rAAV is composed of, na作者: 按時間順序 時間: 2025-3-26 20:56 作者: Reverie 時間: 2025-3-27 03:42 作者: liposuction 時間: 2025-3-27 09:13 作者: 衰老 時間: 2025-3-27 13:02 作者: lethal 時間: 2025-3-27 14:17 作者: configuration 時間: 2025-3-27 20:33
Application of NMR Spectroscopy in Viral Assembly Characterization,tion and solid state. Advances in NMR instrumentation and new pulse sequences have enabled the investigation and characterization of complex biomolecular systems such as viruses or viral-like particles (VLPs). NMR spectroscopy has achieved much success in this area, and it is one of the few techniqu作者: fabricate 時間: 2025-3-27 22:02
Improved Production Strategies for Oncolytic Measles Viruses as a Therapeutic Cancer Treatment,engineering make the oncolytic Measles virus (oMeV) particularly promising for cancer (immuno-)virotherapy. Clinical trials of oMeV indicate an efficient and well-tolerated treatment. However, high doses (10.–10. TCID. or more) are needed per patient, turning the manufacturing process into a bottlen作者: insightful 時間: 2025-3-28 03:46 作者: 可商量 時間: 2025-3-28 07:29 作者: Pathogen 時間: 2025-3-28 12:46 作者: ARENA 時間: 2025-3-28 16:12
http://image.papertrans.cn/b/image/188426.jpg作者: Radiation 時間: 2025-3-28 19:18
Conclusion: The Trials of Lucy Snowe,rspective. Viruses serve as ideal drug delivery units, on one hand providing tissue- and cell type-specific targeting of cargo and on the other hand regulating immune responses to have a therapeutic outcome for instance in immuno-oncology. Virotherapy is an emerging and revolutionary field with high作者: PATRI 時間: 2025-3-29 02:06 作者: 功多汁水 時間: 2025-3-29 03:37 作者: 不規(guī)則的跳動 時間: 2025-3-29 10:39
Conclusion: The Trials of Lucy Snowe,ities of biopharmaceutical development pipelines, with more than 1000 treatments in clinical trials at the end of 2019. The manufacturing demand for virus-based therapies is projected to increase with about 10–20 cell and gene therapies being approved per year by 2025. Many of these therapies requir作者: 人造 時間: 2025-3-29 12:48
https://doi.org/10.1057/9780230358331iral vector production strategies must rapidly evolve to keep up with this increased demand for diversity and yield. Downstream purification processes are often a bottleneck during viral vector manufacturing. Challenges include a lack of standardization, low recovery, poor scalability, and maintaini作者: 多余 時間: 2025-3-29 17:03
https://doi.org/10.1057/9780230358331 Practical considerations are made during these filtration processes to maximize product recovery and process efficiency and robustness. Viral clearance is an integral part of these filtration steps to ensure patient safety.作者: progestin 時間: 2025-3-29 23:47 作者: yohimbine 時間: 2025-3-30 00:09 作者: 商業(yè)上 時間: 2025-3-30 06:28
https://doi.org/10.1007/978-1-349-14295-8eans of providing transformative therapeutic results. However, to be able to fulfill this potential the virus particles must be produced reliably in a high-quality fashion. The properties to which each viral preparation is measured up to are related to the two components that rAAV is composed of, na作者: 暴露他抗議 時間: 2025-3-30 09:00 作者: 痛得哭了 時間: 2025-3-30 15:14 作者: left-ventricle 時間: 2025-3-30 19:11 作者: 群居動物 時間: 2025-3-30 21:35 作者: originality 時間: 2025-3-31 03:00 作者: Surgeon 時間: 2025-3-31 06:48 作者: 劇毒 時間: 2025-3-31 10:38 作者: 寬宏大量 時間: 2025-3-31 17:06 作者: 無表情 時間: 2025-3-31 18:00 作者: CRUC 時間: 2025-4-1 00:08 作者: Tailor 時間: 2025-4-1 03:22 作者: 拱形面包 時間: 2025-4-1 07:08
https://doi.org/10.1057/9780230358331 Practical considerations are made during these filtration processes to maximize product recovery and process efficiency and robustness. Viral clearance is an integral part of these filtration steps to ensure patient safety.作者: glacial 時間: 2025-4-1 12:21
,Murder in the Irish Family, 1930–1945,ormed at room temperature or in cryogenic conditions for electron microscopy are summarized. Additional topics about instrumentation, data processing, correlative light and electron microscopy, selected applications, and future perspectives are included.作者: eustachian-tube 時間: 2025-4-1 18:19
https://doi.org/10.1007/978-3-031-28489-2Viral vectors; Gene therapy; Viral vector analytics; Viral vector DSP & USP; downstream processing; upstr作者: 定點 時間: 2025-4-1 20:58 作者: Euthyroid 時間: 2025-4-1 23:03
Bioprocess and Analytics Development for Virus-based Advanced Therapeutics and Medicinal Products (A作者: inspiration 時間: 2025-4-2 02:48
